跳至主要内容
临床试验/JPRN-UMIN000024257
JPRN-UMIN000024257已完成未知

Association of changes in dyspnea, lung function, and physical activity by Indacaterol/Glycopyrronium combination in patients with COPD - Changes in lung function and physical activity by LAMA/LABA therapy in COPD

Yamaguchi University0 个研究点目标入组 45 人开始时间: 2016年10月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Moderate-to-severe COPD exacerbation (requiring antibiotics, systemic steroids or hospitalization) within the 4 weeks before the screening 2)Requiring LABA and LAMA combination therapy 3)Requiring long-term oxygen therapy 4)Requiring short-acting beta2-agonista (SABA) relief use of more than 8 puffs/day 5)Concomitant pulmonary disease including asthma (FeNO<50ppb at baseline) 6)Any physical disorder that would prevent the patient from being able to complete the assessments 7)Long QT syndrome at screening, or a clinically significant electrocardiogram abnormality 8)History of closed angle glaucoma, and/or ischuria due to prostatic disease 9) There is a history of hypersensitivity to components of the Urutiburo

研究者

相似试验